BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15624658)

  • 1. [Initial combination treatment of hypertension].
    Düsing R
    MMW Fortschr Med; 2004 Nov; 146(47):46-8. PubMed ID: 15624658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy in the treatment of hypertension.
    Escobar C; Barrios V
    Fundam Clin Pharmacol; 2010 Feb; 24(1):3-8. PubMed ID: 19682088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination versus Monotherapy as Initial Treatment in Hypertension.
    Holzgreve H
    Herz; 2003 Dec; 28(8):725-32. PubMed ID: 14689107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recently published European and American guidelines for the diagnosis and treatment of hypertension].
    van Zwieten PA; Struijker Boudier HA; de Leeuw PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):868-71. PubMed ID: 15152386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of hypertensive patients in private practice].
    Imbs JL; Welsch M; Stephan D
    Rev Prat; 1990 Jun; 40(18 Suppl):16-20. PubMed ID: 2385795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare benefits of very-low-dose combination treatment used in the management of hypertension.
    Ambrosioni E
    J Hypertens Suppl; 2001 Nov; 19(4):S29-36. PubMed ID: 11848260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial combination therapy for rapid and effective control of moderate and severe hypertension.
    Franklin SS; Neutel JM
    J Hum Hypertens; 2009 Jan; 23(1):4-11. PubMed ID: 18615100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of resistant hypertension].
    Baumgart P
    Med Klin (Munich); 2005 Apr; 100(4):200-6; quiz 207-8. PubMed ID: 15834529
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple drug therapy in the treatment of essential hypertension.
    Hockenberry B
    Nurs Clin North Am; 1991 Jun; 26(2):417-36. PubMed ID: 2047290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary combination treatment of hypertension. Strategies for improved therapy outcomes].
    Holzgreve H
    MMW Fortschr Med; 2004 Feb; 146(7):47, 49-50. PubMed ID: 15347050
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose fixed combination of bisoprolol/hydrochlorothiazide as first line for hypertension: a review of the rationale and clinical evidence.
    Papadopoulos DP; Papademetriou V
    Angiology; 2009; 60(5):601-7. PubMed ID: 19028769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.